OVERVIEW
Microsphere or microparticle depot injections are complex drug formulations that combine an Active Pharmaceutical Ingredient (API) with a bioresorbable polymer such as PLGA. Microsphere-based injections enable the sustained release of APIs over prolonged periods of time, varying from weeks up to several months.
This webinar, co-presented by Powder Systems Ltd (PSL) and Lubrizol Life Science Health (LLS), will cover microsphere development from start to finish, including early-stage considerations through scale-up and GMP manufacturing. Key topics include:
- The history and current state of microsphere depot injections
- How selecting the right polymers, manufacturing techniques, and downstream processing methods help streamline production
- Advice for overcoming common challenges in microsphere development and manufacturing
- A discussion on sterile fill/finish and characterization considerations for long-acting injections
Whether you are new to the field of microspheres or currently developing a long-acting injectable product, you will benefit from the combined experience of PSL and LLS. Register today to learn more about this exciting area of the pharmaceutical market.
In collaboration with
DETAILS
Date & Time
26th January 2021
16:00 (CET) | 15:00 (GMT) | 10:00 (EST)
Language
English
Location
Online – GoToWebinar
SPEAKERS

Pierre Landais
Director
Global Business Development
Powder Systems Limited

Rob Lee
President
CDMO Division
Lubrizol Life Science Health

Nick DiFranco
Market Manager – Long-Acting
Drug Delivery & Combination Products
Lubrizol Life Science Health